AAVANTGARDE BIO
HQ - Milan
Summary
AAVantgarde Bio is a clinical-stage, biotechnology company pioneering therapies for inherited retinal diseases.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 106 M
Avg. Deal Size£ 106 M
All rights reserved. Copyright © 2025 Datasite
